Outcome of lung transplant recipients with telomere-related and non-telomere-related usual interstitial pneumonia
| Telomere-related# | Non-telomere-related¶ | p-value | |
| Dg–Tx days (min–max) | 1100±629 (439–2460) | 1346±684 (87–2766) | 0.40 |
| List time days (min–max) | 82±99 (1–321) | 82±145 (0–517) | 0.99 |
| Follow-up days (min–max) | 2920±791 (1921–4421) | 2473±1026 (1509–4624) | 0.28 |
| New onset chronic renal insufficiency | 9 (100) | 13 (93) | 0.99 |
| MMF treatment stopped | 0 (0) | 1 (7) | 0.99 |
| Skin malignancies | 4 (44) | 2 (14) | 0.16 |
| Histopathological rejection | 3 (33) | 8 (57) | 0.40 |
| Time to rejection days (min–max) | 59±15 (47–76) | 73±49 (31–176) | 0.63 |
| CLAD | 3 (33) | 6 (43) | 0.99 |
| Time to CLAD days (min–max) | 1475±329 (1102–1724) | 1209±536 (469–1832) | 0.46 |
Data presented as mean±sd or n (%). Dg–Tx: time from diagnosis to transplantation; MMF: mycophenolate mofetil; CLAD: chronic lung allograft dysfunction. #: n=9; ¶: n=14.